SCHEMBL4540900

SCHEMBL4540900

Fc1c(CCNc2ncnc3[nH]cnc23)nc(CCN2CCOCC2)c2c(Cl)cccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.40
CYP1A2 P05177 5/20 0.40
CYP3A4 P08684 4/20 0.40
CYP2D6 P10635 4/20 0.40
CLK4 Q9HAZ1 3/20 0.40
USP2 O75604 3/20 0.40
MAPK1 P28482 2/20 0.40
TSHR P16473 6/20 0.39
CYP2C19 P33261 4/20 0.39
LMNA P02545 3/20 0.39
HIF1A Q16665 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 4/20 0.38
HTT P42858 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
POLB P06746 1/20 0.38
HSD17B10 Q99714 3/20 0.38
ALOX15 P16050 2/20 0.38
PIK3CD O00329 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3701676 0.84 PIK3CD (0.46) CYP1A2CYP3A4CYP2D6CLK4USP2
SCHEMBL3701674 0.84 PIK3CD (0.46) CYP1A2CYP3A4CYP2D6CLK4USP2
SCHEMBL4534806 0.79 SMN1; SMN2 (0.48) ALDH1A1CYP1A2CYP3A4CYP2D6CLK4
SCHEMBL10282370 0.75 PIK3CD (0.39) ALDH1A1CYP1A2CYP3A4CYP2D6CLK4
SCHEMBL4541331 0.75 LRRK2 (0.40) ALDH1A1CYP1A2CYP3A4CYP2D6CLK4
SCHEMBL14329176 0.75 PIK3CD (0.47) CYP1A2CYP3A4CYP2D6CLK4USP2
SCHEMBL4569302 0.75 PIK3CD (0.47) CYP1A2CYP3A4CYP2D6CLK4USP2
SCHEMBL4569336 0.74 PIK3CD (0.41) ALDH1A1LMNAKDM4EHTTPOLB
SCHEMBL4540902 0.72 CYP1A2 (0.35) ALDH1A1CYP1A2CYP3A4CYP2D6CLK4
SCHEMBL4569352 0.72 EGFR (0.38) ALDH1A1CYP1A2CYP3A4CYP2D6CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2637669-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF Infinity Pharmaceuticals, Inc. (US) 2013-09-18 EP disclosed
WO-2012064973-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2012-05-18 WO disclosed